A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the same time.

Mytos’ technology will automate the manufacturing of neuronal precursors for Aspen's autologous cell therapy for the brain disorder.

A new study reveals new insights into ependymal cells and astrocytes and offers a promising approach for future SCI therapies ...

Researchers eventually want to map the effects of every possible mutation on all human proteins to transform precision ...

Zolpidem suppressed norepinephrine oscillations in mouse brains, disrupting the glymphatic system and impeding the brain’s ...

The GMP Engineering & Cell Manufacturing Facility at the Roswell Park Comprehensive Cancer Center is expected to open in ...

VIVEbiotech is also collaborating with a range of different suppliers to make its operations as efficient as possible.

A Danish team thinks it can aid rAAV manufacturers, who may not be able to spend three to five years working on a project ...

Combining a weakly hydrophobic ion-pairing agent with a moderately hydrophobic one further improved resolution.

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...